Rules-Based Medicine, Inc.
Commercial services regarding Multi-Analyte Profiles (MAPs)
Rules-Based Medicine, Inc. was started in 1998 initially with research and development, culminating in a commercial launch in 2002.
Craig Benson (CEO)
Patrick McClain (CFO)
James P. Mapes (CSO)
3300 Duval Road
Austin, TX 78759
USA
Phone: +1-512-835-8026
Fax: +1-512-835-4687
Related news
- Rules-Based Medicine, Inc. Awarded Funding from the Cancer Prevention and Research Institute of Texas
- Rules-Based Medicine and Psynova Neurotech Announce Companion Diagnostic Collaboration with Roche
- Rules-Based Medicine Introduces CardiovascularMAP™ Multiplex Biomarker Panel To Aid CVD Development
- Rules-Based Medicine, Inc. and Psynova Neurotech Ltd. Identify Diagnostic Biomarker Panel for Schizophrenia
- Rules-Based Medicine, Inc. Launches DiscoveryMAP™ Service for Drug and Diagnostic Development
- Rules-Based Medicine Partners With EMD to Develop and Distribute Multi-Analyte Kits
- Rules-Based Medicine Raises $25 Million in Series A Funding
- Rules-Based Medicine Awarded Phase II STTR Grant by U.S. Department of Defense
- Rules-Based Medicine and Multiplex Biosciences Merge